For the Inventor, By the Inventor

Enter assignee name

Bern, Switzerland

Csl Behring Ag

USPTO Granted Patents = 28

% Expired Patents = 7.1

CIPO Patents = 4

EPO Patents = 17

Trademarks = 12

Forward Citations = 168

Loading Chart...

Loading Chart...

48 inventors (with patents filed for the assignee):

Reinhard Franz Bolli (9 out of 18 patents)

Werner Maeder (7 out of 7 patents)

Peter Lerch (7 out of 10 patents)

4. Sylvia Miescher (6 out of 11 patents)

5. Renzo Pedrussio (5 out of 5 patents)

6. Ibrahim El Menyawi (4 out of 4 patents)

7. Nathan Brinkman (4 out of 7 patents)

8. Liane Hoefferer (4 out of 4 patents)

9. Cédric Pierre Vonarburg (3 out of 3 patents)

10. Adrian Zuercher (3 out of 10 patents)

11. Blaise Corthésy (2 out of 2 patents)

12. Marius Loetscher (2 out of 2 patents)

13. Doreen Siegemund (2 out of 2 patents)

14. Regula Styger (2 out of 3 patents)

15. Gilles Bioley (1 out of 3 patents)

Core Competencies:

Immunoglobulin Preparation

Hemopexin Formulations

Protein Extraction

CIDP Treatment

Infection Prevention

IgG Purification

IgA Enrichment

Antibody Composition

Inflammatory Conditions

Pharmaceutical Stability

Nebulization

Mucositis Treatment

28 patents: Sort by Forward Citations

1. 12559520 - Method for extracting a protein from a precipitate and method for precipitating impurities (2026-02-24),

2. 12558422 - Immunoglobulin preparation and storage system for an immunoglobulin preparation (2026-02-24),

3. 12396943 - Hemopexin formulations (2025-08-26),

4. 12325738 - Treatment of CIDP (2025-06-10),

5. 12194101 - Process for preparing an immunoglobulin preparation (2025-01-14),

6. 12144861 - Pharmaceutical product with increased stability comprising immunoglobulins (2024-11-19),

7. 11471617 - Nebultzation of immunoglobulin (2022-10-18),

8. 11419936 - Immunoglobulin preparation and storage system for an immunoglobulin preparation (2022-08-23),

9. 11312746 - Method and system of protein extraction (2022-04-26),

10. 10918696 - Methods of treatment using hemopexin compositions (2021-02-16),

11. 10829542 - Methods for affectinginfections (2020-11-10),

12. 10434176 - Immunoglobulin preparation and storage system for an immunoglobulin preparation (2019-10-08),

13. 10221233 - Compositions comprising secretory-like immunoglobulins (2019-03-05),

14. 10144774 - Method for purifying IgG (2018-12-04),

15. 10137197 - Process for preparing an immunoglobulin preparation (2018-11-27),

Company Overview

CSL Behring AG is a global leader in the development and manufacture of innovative therapies for people with serious and rare diseases. The company specializes in biopharmaceuticals derived from human plasma, focusing on treatments for conditions such as hemophilia, immunodeficiencies, and other chronic diseases. With a commitment to research and development, CSL Behring operates in various regions, ensuring access to life-saving therapies for patients worldwide while advancing the science of protein-based therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

28 Patents

#11 in Bern

#473 in Switzerland

#23,262 in the World

Bern, Switzerland

Csl Behring Ag

Forward Citations = 168

48 inventors:

Reinhard Franz Bolli (9 out of 18 patents)

Werner Maeder (7 out of 7 patents)

Peter Lerch (7 out of 10 patents)

4. Sylvia Miescher (6 out of 11 patents)

5. Renzo Pedrussio (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Csl Behring Ag. Retrieved from https://idiyas.com/company/csl-behring-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…